Anand Tanya, Hejazi Omar, Nelson Adam, Litmanovich Ben, Spencer Audrey L, Khurshid Muhammad Haris, Ghaedi Arshin, Hosseinpour Hamidreza, Magnotti Louis J, Joseph Bellal
Division of Trauma, Critical Care, Burns, and Emergency Surgery, Department of Surgery, College of Medicine, University of Arizona, Tucson, AZ, USA.
Am Surg. 2025 Jan;91(1):22-30. doi: 10.1177/00031348241269425. Epub 2024 Jul 30.
Optimal utilization of vasopressors during early post-injury resuscitation remains unclear. Our study aims to describe the relationship between the timing of vasopressor administration and outcomes among hypotensive trauma patients.
This was a retrospective analysis of the 2017-2018 ACS-TQIP database. We included adult (≥18 years) trauma patients presenting with hypotension (lowest SBP <90 mmHg) who received vasopressors within 6 hours of admission. We excluded patients who had a severe head injury (Head-AIS >3) and those with spinal cord injury (Spine-AIS >3). Patients were stratified based on the time to receive vasopressors. Multivariable regression analyses were performed to identify the independent association between timing of vasopressor initiation and outcomes.
1049 patients were identified. Mean age was 55 ± 20 years, and 70% of patients were male. The median ISS was 16 [9-24], 80% had a blunt injury, and the mean SBP was 61 ± 24 mmHg. The median time to first vasopressor administration was 319 [68-352] minutes. Overall, 24-hour and in-hospital mortality rates were 19% and 33%, respectively. Every one-hour delay in vasopressor administration beyond the first hour was independently associated with decreased odds of 24-hour mortality (aOR: 0.65, < 0.001), in-hospital mortality (aOR: 0.65, < 0.001), major complications (aOR: 0.77, = 0.003), and increased odds of longer ICU LOS (β + 2.53, = 0.012). There were no associations between the timing of early vasopressor administration and 24-hour PRBC transfusion requirements ( > 0.05).
Earlier vasopressor requirement among hypotensive trauma patients was independently associated with increased mortality and major complications. Further research on the utility and optimal timing of vasopressors during the post-injury resuscitative period is warranted.
III therapeutic/care management.
创伤后早期复苏期间血管升压药的最佳使用尚不清楚。我们的研究旨在描述血管升压药给药时机与低血压创伤患者预后之间的关系。
这是一项对2017 - 2018年美国外科医师学会创伤质量改进项目(ACS - TQIP)数据库的回顾性分析。我们纳入了成年(≥18岁)创伤患者,这些患者入院时出现低血压(最低收缩压<90 mmHg)且在入院6小时内接受了血管升压药治疗。我们排除了重度颅脑损伤(头部损伤严重程度评分[Head - AIS]>3)和脊髓损伤(脊柱损伤严重程度评分[Spine - AIS]>3)的患者。根据接受血管升压药的时间对患者进行分层。进行多变量回归分析以确定血管升压药起始时机与预后之间的独立关联。
共纳入1049例患者。平均年龄为55±20岁,70%为男性。损伤严重程度评分(ISS)中位数为16[9 - 24],80%为钝性损伤,平均收缩压为61±24 mmHg。首次使用血管升压药的中位时间为319[68 - 352]分钟。总体而言,24小时和住院死亡率分别为19%和33%。在第一小时之后,血管升压药给药每延迟一小时,24小时死亡率(校正比值比[aOR]:0.65,P<0.001)、住院死亡率(aOR:0.65,P< 0.001)、主要并发症(aOR:0.77,P = 0.003)的发生几率独立降低,而入住重症监护病房(ICU)时间延长的几率增加(β + 2.53,P = 0.012)。早期血管升压药给药时机与24小时红细胞输注需求之间无关联(P>0.05)。
低血压创伤患者更早需要血管升压药与死亡率增加和主要并发症独立相关。有必要对创伤后复苏期血管升压药的效用和最佳时机进行进一步研究。
III级治疗/护理管理。